Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 The data of dynamic observation of 205 MS patients, started GA therapy in 2000

From: Long-term results of the first line DMT depend on the presence of minimal MS activity during first years of therapy: data of 15 years observation

Time Treated Discontinued the GA therapy
  Started Continues Clinical failure (including change to SPMS course) Tolerability and side effects Others (including pregnancies, deaths, migration, escaping from observation, etc.)
Baseline 205     
3 years   155 (76 %) 37 (18 %) 8 (4 %) 5 (2 %)
  155     
5 years   91 (59 %) 42 (28 %) 12 (8 %) 7 (5 %)
  91     
10 years   74 (81 %) 10 (11 %) 2 (2 %) 5 (3 %)
  74     
15 years   69 (93 %) 1 (1 %) 1 (%) 3 (5 %)
  69     
  Continues 35 Stopped 34